Schneider J, Jimenez E, Rodriguez F, del Tanago J G
Hospital de Cruces, Departamento de Ginecologia, Baracaldo, Spain.
Oncol Rep. 1998 Jan-Feb;5(1):49-52. doi: 10.3892/or.5.1.49.
We studied the expression of oncogenes and tumor-suppressor genes in human endometriosis in a retrospective pilot study. Sixteen patients with histologically verified pelvic endometriosis at the university-based tertiary care referral center were studied. Immunohistochemical determination of c-myc, c-erb-B2, nm23 and p53 expression in archival, paraffin-embedded pathological samples were used from patients operated upon for pelvic endometriosis. c-myc was expressed in 8/15 cases (53.3%). nm23 was expressed in 7/16 cases (43.7%). c-erb-B2 and p53 reactivity was undetectable in the samples studied. The c-myc oncogene and nm23 are overexpressed in many cases of endometriosis, and may play a still undefined role in its pathogenesis. Immuno-histochemistry is a useful tool for the study of oncogenic activation in this disease.
在一项回顾性初步研究中,我们研究了人子宫内膜异位症中癌基因和肿瘤抑制基因的表达。对一所大学附属三级医疗转诊中心的16例经组织学证实患有盆腔子宫内膜异位症的患者进行了研究。我们利用盆腔子宫内膜异位症手术患者的存档石蜡包埋病理样本,通过免疫组织化学法测定c-myc、c-erb-B2、nm23和p53的表达。c-myc在8/15例(53.3%)中表达。nm23在7/16例(43.7%)中表达。在所研究的样本中未检测到c-erb-B2和p53的反应性。c-myc癌基因和nm23在许多子宫内膜异位症病例中过度表达,可能在其发病机制中发挥尚未明确的作用。免疫组织化学是研究该疾病致癌激活的有用工具。